PCV34 COST-EFFECTIVENESS OF ANTICOAGULATION WITH BIVALIRUDIN VS. HEPARIN AND GLYCOPROTEIN INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN SWEDEN
Abstract
Authors
S Borg U Persson TB Conradson K Ericsson